argenx SE
$249.749876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$249.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$5.28 (+2.16%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell argenx SE and other stocks, options, ETFs, and crypto commission-free!
About ARGX
argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. Read More The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.
Employees
188
Headquarters
Breda, Noord-Brabant
Founded
2008
Market Cap
11.74B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
228.99K
High Today
$249.98
Low Today
$242.73
Open Price
$242.73
Volume
297.23K
52 Week High
$272.74
52 Week Low
$103.75
Collections
Analyst Ratings
77%
of 22 ratings
Buy
77%
Hold
23%
Sell
0%
ARGX Earnings
-$3.15
-$2.04
-$0.92
$0.19
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Available Oct 22, Pre-Market